1
A Study to Evaluate the Safety and Pharmacokinetic of Recombinant Human Coagulation Factor VIII, Fc Fusion Protein for Injection
Condition(s):Hemophilia ALast Updated:June 30, 2022Recruiting
Factor VIII: 842 Clinical Trials, Page 1 of 85
Hide Studies Not Open or Pending
2
Pharmacokinetics Evaluation of Recombinant Coagulation Factor VIII Injection in Subjects With Hemophilia A.
Condition(s):Hemophilia ALast Updated:August 19, 2019Unknown status
3
Efficacy and Cost Effectiveness of Pharmacokinetic Dosing in Haemophilia A
Condition(s):Severe Haemophilia ALast Updated:February 23, 2018Completed
4
Moroctocog Alfa (AF-CC) for Prophylaxis and Treatment of Bleeding Episodes in Previously Treated Hemophilia A Patients
Condition(s):Hemophilia ALast Updated:May 3, 2021Completed
5
A Study to Evaluate the Pharmacokinetics，Safety and Tolerability of PEG Recombinant Human Coagulation Factor VIII-Fc Fusion Protein for Injection
Condition(s):Severe Hemophilia ALast Updated:June 30, 2022Completed
6
Immune Tolerance Induction in Haemophilia A Patients Using Wilate or Nuwiq
Condition(s):Hemophilia ALast Updated:February 23, 2021Terminated
7
Gene Therapy Trial for Platelet Derived Factor VIII Production in Hemophilia A
Condition(s):Hemophilia ALast Updated:October 26, 2021Recruiting
8
A Study to Determine How a Virtual-reality Based Solution May Reduce the Treatment Burden of Children, Teenagers and Adults With Hemophilia A Who Receive Prophylactic Factor VIII Infusions
Condition(s):Hemophilia ALast Updated:June 29, 2022Not yet recruiting
9
Efficacy and Safety of ADVATE Standard Prophylaxis to Hemophilia A
Condition(s):Hemophilia ALast Updated:October 31, 2014Unknown status
10
Evaluate Efficacy and Safety of ADVATE in the Standard Prophylaxis Treatment of Severe or Moderately Severe Hemophilia A
Condition(s):Hemophilia ALast Updated:November 4, 2014Unknown status